You have 9 free searches left this month | for more free features.

City

Shanghai (1)

Condition

Breast Cancer (2)

Metastatic Cancer (2)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Fudan University (2)

Collaborator

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

serd

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)

Recruiting

Breast Cancer
Metastatic Cancer

SHR7390
+14 more

Shanghai, Shanghai, China

Cancer Hospital Affiliated to Fudan University

Jul 22, 2022

Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)

Not yet recruiting

Breast Cancer
Metastatic Cancer

SHR-1316
+4 more

(no location specified)

Jan 11, 2022